NEW SOUTHGATE SURGERY
BUXTON PLACE, WAKEFIELD
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 50 | 60 | 83.3% | |
| CKD 4 | 2008 | 126 | 145 | 86.9% | |
| CKD 5 | 2009 | 18 | 21 | 85.7% | |
| CKD 5 | 2010 | 35 | 35 | 100.0% | |
| CKD 5 | 2011 | 57 | 60 | 95.0% | |
| CKD 5 | 2012 | 64 | 70 | 91.4% | |
| CKD 5 | 2013 | 69 | 78 | 88.5% | |
| CKD003 | 2014 | 68 | 80 | 85.0% | |
| CKD003 | 2015 | 69 | 77 | 89.6% | |
| NM84 | 2016 | 57 | 70 | 81.4% | |
| NM84 | 2017 | 60 | 75 | 80.0% | |
| NM84 | 2018 | 59 | 73 | 80.8% | |
| NM84 | 2019 | 52 | 68 | 76.5% | |
| NM84 | 2020 | 47 | 64 | 73.4% | |
| NM84 | 2022 | 34 | 46 | 73.9% | |
| NM84 | 2023 | 27 | 39 | 69.2% |
